Illustrative image – not actual.Neuland Laboratories, a global contract development and manufacturing organisation (CDMO) focused on complex active pharmaceutical ingredients (APIs), is set to establish a dedicated process development laboratory and integrated kilo lab at its Genome Valley campus in Hyderabad.
The new facility, spanning 1,35,000 sq. ft., will involve an investment of USD 20 million for specialised fit-out and will be operationalised in phases, with full completion targeted by October 2026. The centre is designed as a purpose-built integrated scale-up laboratory exclusively dedicated to process development, significantly enhancing the company’s R&D capabilities. Once fully operational, it will expand Neuland’s process development team to over 500 scientists, positioning it among the largest scale-up workforces in India. The facility will integrate advanced technologies such as AI-driven route scouting, parallel synthesis, and electronic laboratory notebooks to improve efficiency, reduce development cycles, and ensure seamless data management. It will also feature a centralised analytical wing equipped with advanced characterisation tools, along with specialised zones for process engineering, polymorph studies, process safety, flow chemistry, peptide research, and purification.
The kilo lab will include advanced reactors and filtration systems, enabling smooth transition from laboratory-scale chemistry to commercial manufacturing processes with enhanced scalability and reliability.
